GCC Nurse Guide: IV Therapy & Intravenous Fluid Management

△ Body Fluid Compartments

Total body water is approximately 60% of body weight in adults (lower in females and obese patients).

Intracellular Fluid (ICF) — 60% of TBW

Rich in potassium (K+), phosphate, magnesium. Separated from ECF by cell membrane Na+/K+ ATPase pump.

Extracellular Fluid (ECF) — 40% of TBW

Intravascular (plasma) — ~25% of ECF; direct IV access point. Rich in Na+, Cl-, albumin.
Interstitial — ~75% of ECF; fluid between cells. Site of oedema formation.
Transcellular — CSF, pleural, peritoneal, synovial (small volume, clinical significance in ascites/effusions).

ICF 60% ECF 40% Plasma 8% TBW Interstitial 32% TBW

⇋ Tonicity & Osmolality

Normal plasma osmolality: 280–295 mOsm/kg. Tonicity describes the effect of a solution on cell volume.

Tonicity	Osmolality	Cell Effect	Example
Isotonic	~280–310 mOsm/kg	No change	0.9% NaCl, Hartmann's
Hypotonic	<280 mOsm/kg	Cell swells	0.45% NaCl, 5% Dextrose*
Hypertonic	>310 mOsm/kg	Cell shrinks	3% NaCl, 50% Dextrose

*5% Dextrose is isotonic in the bag but becomes hypotonic once glucose is metabolised.

Clinical Pearl

Serum osmolality = 2 x [Na+] + [glucose mmol/L] + [urea mmol/L]. Effective osmolality excludes urea (freely permeable).

◆ Starling Forces & Oedema

Starling Forces

Capillary hydrostatic pressure (Pc) — pushes fluid out of capillary.
Interstitial hydrostatic pressure (Pi) — opposes filtration.
Plasma oncotic pressure (πc) — pulls fluid into capillary (mainly albumin ~25 mmHg).
Interstitial oncotic pressure (πi) — pulls fluid out.

Net filtration = (Pc - Pi) - (πc - πi). Normally slight net outward filtration balanced by lymphatic drainage.

Causes of Oedema (Starling Breakdown)

Raised Pc: heart failure, venous obstruction, aggressive IV fluid therapy
Reduced πc: hypoalbuminaemia (liver disease, malnutrition, nephrotic syndrome)
Lymphatic obstruction: post-surgery, filariasis, malignancy
Capillary leak: sepsis, ARDS, burns — colloids less effective

Key point: In sepsis with capillary leak, colloids leak into interstitium and worsen oedema — crystalloids preferred.

■ Crystalloids vs Colloids

Property	Crystalloids	Colloids
Composition	Water + electrolytes ± glucose	Water + large molecules (albumin, starches, gelatins)
Distribution	All ECF compartments	Mainly intravascular (initially)
Volume expansion per 1L	~250 mL intravascular (0.9% NaCl)	~700–800 mL (albumin)
Evidence (sepsis)	Preferred (SAFE, CRISTAL trials)	No mortality benefit; harm with HES in sepsis/AKI
Cost	Low	High (especially albumin)
Examples	0.9% NaCl, Hartmann's, 5% Dextrose	4% Albumin, Gelofusine, Voluven (HES)

NICE recommendation: Use crystalloids (balanced isotonic) as first-line for resuscitation and maintenance. Reserve colloids for specific indications only (e.g. albumin in cirrhosis/SBP, specific surgical protocols).

◆ Individual Crystalloid Fluids

0.9% Normal Saline (NaCl)

Na+ 154 mmol/L, Cl- 154 mmol/L. Isotonic (308 mOsm/L). Commonly used but NOT physiologically balanced.

Hyperchloraemic metabolic acidosis: Large volumes deliver excess Cl- (154 vs plasma 102 mmol/L) — dilutional acidosis, renal vasoconstriction, impaired renal function. Use with caution in large-volume resuscitation.

Indications: Hypochloraemic alkalosis, head injury (avoid hypotonic solutions), medication dilution per SPC, DKA (first fluid in many protocols).

Hartmann's Solution / Ringer's Lactate

Na+ 131, K+ 5, Ca2+ 2, Cl- 111, Lactate 29 mmol/L. Osmolality 278 mOsm/L. Balanced, most physiological crystalloid.

Preferred for most situations. Reduces risk of hyperchloraemic acidosis. Lactate is metabolised to bicarbonate by liver. Avoid in severe liver failure.

Indications: Resuscitation, peri-operative fluids, bowel surgery, general maintenance. Avoid in hyperkalaemia (contains K+).

5% Dextrose

Glucose 50g/L, 278 mOsm/L. Isotonic in bag — becomes hypotonic once glucose metabolised. No electrolytes.

Distributes across ALL body compartments (ICF + ECF) — only 1/14 remains intravascular. Not for volume expansion.

Indications: Hypoglycaemia, free water replacement, drug dilution (specific drugs), providing glucose in starvation.

Risk: Hyponatraemia, cerebral oedema if used inappropriately. Never use as resuscitation fluid.

Dextrose-Saline (0.18% NaCl + 4% Dextrose)

Na+ 30 mmol/L, Cl- 30 mmol/L, Glucose 40g/L. Hypotonic (284 mOsm/kg).

Indications: Paediatric maintenance, providing some Na+ with glucose for patients who cannot eat. Not suitable for resuscitation.

Risk of hyponatraemia — monitor electrolytes. NICE CG174 advises caution in surgical and paediatric patients.

Hypertonic Saline

Available as 1.8%, 3%, 7.5% NaCl. Highly concentrated — pulls water from ICF to ECF/intravascular.

1.8%: Severe symptomatic hyponatraemia (cautious correction — max 10–12 mmol/L/24hr to avoid CPM)
3%: Cerebral oedema, raised ICP
7.5%: Haemorrhagic shock (small volume resuscitation), severe TBI in prehospital

ICU/HDU use only. Requires close electrolyte monitoring. Risk of CPM (central pontine myelinolysis) with rapid correction of hyponatraemia.

Colloids (Overview)

Human Albumin Solution (HAS): 4–5% for volume, 20–25% for oncotic pressure. Evidence-based use in cirrhosis/SBP (NICE), large-volume paracentesis.

Gelofusine (Succinylated Gelatin): Synthetic colloid. Rarely indicated. Anaphylaxis risk. Limited evidence.

Voluven (HES — Hydroxyethyl Starch): CONTRAINDICATED in sepsis, AKI, ICU patients (VISEP, 6S, CHEST trials — increased mortality and AKI). Use is highly restricted globally.

Avoid HES in sepsis, AKI, or critically ill patients.

ANTT Principle: Aseptic Non-Touch Technique must be applied for ALL IV access procedures. Key-part and key-site protection at all times.

▼ Peripheral Cannula — Gauge Selection

Gauge	Colour	Flow Rate	Primary Indications
14G	Orange	~270 mL/min	Rapid fluid resuscitation, massive transfusion, major trauma. Largest peripheral cannula.
16G	Grey	~180 mL/min	Blood transfusion, major surgery, large-volume fluid therapy.
18G	Green	~90 mL/min	Standard adult IV access, CT contrast injection, blood products. Most common choice.
20G	Pink	~60 mL/min	Standard adult, paediatrics, patients with fragile veins. Good for most medications.
22G	Blue	~36 mL/min	Elderly patients, difficult IV access, small veins. Slow infusions only.
24G	Yellow	~22 mL/min	Neonates, fragile/small veins, very small paediatrics.

Larger gauge number = smaller cannula = lower flow rate. Use largest cannula appropriate for clinical need and vein size.

■ Site Selection

Preferred Sites (proximal to distal preference for insertion):

Forearm (cephalic, basilic, median veins): Preferred — good flow, less movement, lower phlebitis rate
Dorsum of hand: Accessible but higher phlebitis risk, painful, avoid for vesicants
Antecubital fossa (AC): Largest and easiest — but LEAST preferred for long-term use; restricts elbow movement, high infiltration risk

Sites to Avoid:

Lower limb/foot (unless no other access — high DVT/infection risk)
Femoral area
Affected limb post-mastectomy / lymphoedema
AV fistula arm
Flexion points (wrist/AC) — if avoidable
Area of infection or phlebitis
Antecubital fossa for vesicant drugs

⊕ Insertion Technique (Step-by-Step)

Gather equipment — cannula, tourniquet, chlorhexidine swabs, transparent dressing, extension set, 10mL NaCl 0.9% flush, sharps bin within reach
Explain procedure, gain verbal consent, position patient
Apply tourniquet 5–10 cm above site; engorge vein (warm, hang limb down, pump fist)
Perform hand hygiene; apply non-sterile gloves
Skin preparation: Chlorhexidine 2% in 70% alcohol — scrub 30 seconds, allow to DRY completely (30 seconds). Do not repalpate.
Anchor vein below insertion point with non-dominant thumb
Bevel UP — insert at 15–30 degrees to skin
Advance until flashback of blood seen in chamber
Reduce angle, advance cannula 2–3mm further, then thread plastic cannula off needle while withdrawing needle
Release tourniquet; apply pressure proximal to tip; remove needle fully (into sharps bin immediately)
Connect primed extension set / cap; flush with 10mL 0.9% NaCl
Secure with transparent semi-permeable dressing (e.g. IV3000, Tegaderm) — date label
Document: date/time, gauge, site, attempts, VIP score 0

▲ VIP Score — Visual Infusion Phlebitis

Assess ALL peripheral cannulas every shift. Document score. Remove if score ≥ 2.

No signs. Continue observation.

Slight pain OR redness near site. Observe.

Pain + redness/swelling. Re-site.

Pain + redness + streak. Re-site. Notify.

Palpable venous cord. Re-site. Treat.

Purulent discharge. Thrombophlebitis. Remove + treat + culture.

Peripheral cannulas should be replaced every 72–96 hours or sooner if clinically indicated. Remove when no longer required — minimum dwell time reduces infection risk.

→ Midline Catheter

Length: 10–20 cm, inserted in antecubital area, tip rests in axillary/subclavian vein (NOT central)
Dwell time: up to 4 weeks
Suitable for: antibiotics, fluids, medications of pH 5–9
NOT suitable for: Blood products, concentrated glucose, TPN, vasoactives, vesicants, pH <5 or >9 drugs
Does not require CXR confirmation (non-central)
Requires ANTT for insertion + dressing changes

■ Central Lines (PICC & CVC)

For full detail refer to the Central Line & VAD Guide. Key points:

PICC: Tip at cavoatrial junction. Requires CXR confirmation. Suitable for vesicants, TPN, long-term antibiotics.
CVC (Internal Jugular / Subclavian / Femoral): Ultrasound-guided insertion preferred. Complications: pneumothorax, haemothorax, arterial puncture, CLABSI.
CLABSI prevention: Maximal sterile barrier, chlorhexidine-impregnated dressings, daily necessity review, hub decontamination ("scrub the hub" 15 seconds).
Lines must be reviewed daily — remove when no longer indicated.

NICE CG174 (IV Fluids in Adults in Hospital): Assess patients in 4 categories — Resuscitation, Routine Maintenance, Replacement, Redistribution. Use the 5 Rs: Resuscitation, Routine maintenance, Replacement, Redistribution, Reassessment.

▲ 1. Resuscitation Fluids

Indication: Haemodynamic instability — shock (septic, hypovolaemic, haemorrhagic, anaphylactic).

Fluid Challenge Technique (NICE CG174)

Administer 500 mL crystalloid bolus over 15 minutes (250 mL if frail, cardiac/renal compromise)
Reassess HR, BP, urine output, peripheral perfusion, JVP, SpO2, NEWS score
If improvement — reassess whether further bolus required
If no improvement — seek senior review immediately; consider vasopressors (escalate to ICU)
If worsening — stop; consider cardiogenic cause

Fluid Responsiveness Assessment

Passive Leg Raise (PLR): Gold standard for dynamic assessment. Raise legs to 45° for 1 minute (autotransfusion ~300 mL). If CO/BP increases >10% — fluid responsive. Reversible test — safe in cardiac/renal patients.

Pulse Pressure Variation (PPV): Only valid in mechanically ventilated patients in sinus rhythm with no spontaneous breaths. PPV >13% suggests fluid responsiveness. Requires arterial line for accurate measurement.

Fluid choice in resuscitation: Balanced crystalloid (Hartmann's/Ringer's Lactate) preferred over 0.9% NaCl for most resuscitation. Use blood products early in haemorrhagic shock (target 1:1:1 PRBC:FFP:PLT).

■ 2. Routine Maintenance (NICE CG174)

For adults who cannot meet needs enterally. Target over 24 hours:

Parameter	Daily Requirement	Notes
Water	25–30 mL/kg/day	Reduce if fluid overloaded, renal failure, SIADH. Increase if fever, losses.
Sodium	1 mmol/kg/day	Approx 50–100 mmol/day. Excess Na+ causes fluid retention.
Potassium	1 mmol/kg/day	Approx 40–80 mmol/day. Requires monitoring and supplementation in bags or separate infusion.
Chloride	1 mmol/kg/day	Provided alongside Na/K salts.
Glucose	50–100 g/day	Prevents starvation ketosis and provides minimal caloric intake.

Standard regimen example: 1L 0.18% NaCl/4% Dextrose + 20 mmol KCl over 8 hours × 3 bags in 24 hours. Adjust based on electrolytes, weight, clinical status.

Caution: Avoid excessive 0.9% NaCl for maintenance — use balanced solutions. Reassess IV fluid need daily — consider enteral route as soon as possible.

◆ 3. Replacement of Deficits & Redistribution

Replacement

Address ongoing losses beyond normal maintenance. Calculate and replace:

Vomiting / NG drainage — replace with 0.9% NaCl + KCl (high Cl- loss)
Diarrhoea — replace with Hartmann's (similar to stool electrolytes)
Fistula / stoma output — analyse fluid, replace like-for-like
Burns fluid (Parkland formula for resuscitation)
Haemorrhage — blood products + crystalloid

Redistribution / Special Circumstances

Third space losses: Peritonitis, burns, pancreatitis — large volumes sequestered in tissues; replace with crystalloid but monitor carefully
Post-operative: Minimise IV fluids — use goal-directed therapy in major surgery
Cardiac/renal: Strict fluid restriction; consider daily weights, strict fluid balance
Liver cirrhosis: Albumin 20% for SBP, HRS, large-volume paracentesis

⚠ Avoiding Harm: Over-resuscitation Warning Signs

Respiratory: Worsening SpO2, new crackles, increased respiratory rate, pulmonary oedema on CXR

Cardiovascular: Raised JVP/CVP, hypertension, peripheral oedema (pitting), raised third heart sound

Renal/Other: Falling urine output despite fluid, dilutional hyponatraemia, weight gain >1kg/day

Review IV fluid need daily. Stop when patient can tolerate enteral fluids/feeds. Perform a fluid balance audit — input vs output — every 24 hours.

■ IV Rate Calculations

Formula	Calculation
mL/hour	Volume (mL) ÷ Time (hours)
Drops/minute (gravity)	[Volume (mL) × Drop factor] ÷ [Time (minutes)]
Time to complete (hours)	Volume (mL) ÷ Rate (mL/hr)

Drop factors: Blood administration sets = 15 drops/mL | Standard giving sets = 20 drops/mL | Paediatric/Burette = 60 drops/mL | Macro drip (some countries) = 10 drops/mL

◇ Interactive IV Calculators

▷ Drip Rate Calculator

Volume (mL)

Hours

Minutes

Drop Factor (drops/mL)

Enter values above and press Calculate.

▷ Maintenance Fluid Calculator

Patient Weight (kg)

Age Group

Enter weight and age group above and press Calculate.

HIGH-ALERT MEDICATIONS: All IV electrolyte additives carry significant risk of patient harm if administered incorrectly. Concentrated potassium chloride is classified as a NEVER EVENT if given undiluted IV. Dual-nurse independent check required for all electrolyte additive preparations and administration.

⚠ Potassium Chloride (KCl) — ISMP High-Alert

Critical Safety Rules

NEVER give concentrated KCl (undiluted) IV — causes immediate cardiac arrest
Concentrated KCl ampoules must NOT be stored on ward floors (JCI requirement — GCC mandate)
Use pharmacy-prepared pre-mixed bags wherever possible
Smart pump with drug library programming REQUIRED
Dual-nurse independent check: drug, dose, rate, patient ID, route
Continuous cardiac monitoring required for rates >10 mmol/hr

Peripheral Administration Limits

Max concentration peripheral: 40 mmol/L (higher concentrations cause chemical phlebitis)
Max rate peripheral: 10 mmol/hr
Concentrations up to 80 mmol/L acceptable via central line (with cardiac monitoring)

Standard Pre-mixed KCl Bags (GCC)

Bag	KCl Content	Concentration
0.9% NaCl 1L + KCl	20 mmol	20 mmol/L
0.9% NaCl 1L + KCl	40 mmol	40 mmol/L
0.18% NaCl/4% Dex + KCl	20 mmol	20 mmol/L

Verify before connecting: Always check the KCl concentration on the bag label before administration. 20 mmol vs 40 mmol bags look similar — independent double-check is essential.

Hypokalaemia Management

Mild (3.0–3.5 mmol/L): Oral KCl preferred if patient can tolerate

Moderate (2.5–3.0 mmol/L): IV via peripheral at 10 mmol/hr with monitoring

Severe (<2.5 mmol/L or symptomatic): IV via central line, continuous cardiac monitoring, HDU/ICU setting

⊕ IV Magnesium Sulphate (MgSO4)

Indications & Dosing

Arrhythmia (torsades de pointes): 2g (8 mmol) over 10–15 min IV
Acute severe asthma: 2g over 20 min IV (once only)
Hypomagnesaemia: 10–20 mmol over 1–2 hours (rate 1–2 g/hr)
Eclampsia loading: 4g over 5–15 minutes IV, then 1g/hr maintenance (Zuspan regimen)
Pre-eclampsia seizure prophylaxis: 4g loading then 1g/hr × 24 hrs post-delivery

Toxicity Monitoring (MgSO4)

Mg Level	Effect	Action
0.7–1.0 mmol/L	Normal	Continue
1.5–2.5 mmol/L	Therapeutic (eclampsia)	Monitor
2.5–3.5 mmol/L	Loss of patellar reflex	Stop infusion
>5 mmol/L	Respiratory arrest, cardiac arrest	Calcium gluconate IV + resuscitation

Antidote: Calcium gluconate 10 mL of 10% IV over 3 min for MgSO4 toxicity.

◆ IV Phosphate Replacement

Indications

Hypophosphataemia (<0.8 mmol/L) — causes: refeeding syndrome, DKA, malnutrition, alcoholism, prolonged TPN without phosphate.

Administration

Moderate hypophosphataemia (0.3–0.8 mmol/L): IV phosphate at cautious rate
Severe (<0.3 mmol/L): Urgent replacement — seek pharmacy guidance for rate/dose
Typical rate: 9–18 mmol over 12–24 hours (adjust to renal function)

Precipitation risk: Calcium and phosphate will precipitate if mixed in the same line or bag. Never co-administer through the same lumen without pharmacist verification. Flush lines thoroughly between infusions.

Refeeding Syndrome

Risk: >5 days starvation, malnourished patients, chronic alcohol misuse. Introduce nutrition gradually. Monitor K+, Mg2+, PO4- closely. IV thiamine before feeding in at-risk patients.

◆ Infiltration vs Extravasation

Feature	Infiltration	Extravasation
Definition	Non-vesicant fluid leaks into surrounding tissue	Vesicant/irritant drug leaks into tissue — causes damage
Cause	Dislodged cannula, venous fragility	Same + high-risk drugs
Tissue damage	Minimal — resolves spontaneously	Severe — necrosis, blistering, permanent damage
Pain	Often minimal	Often painful, burning sensation
Blanching	Possible	Yes — blanched, cool skin
Management	Stop infusion, elevate, warm compress	Stop + aspirate + antidote + photograph + document

⚠ Vesicant Drugs — High Extravasation Risk

The following drugs cause significant tissue damage if extravasated:

Chemotherapy agents Vancomycin IV Calcium chloride/gluconate 50% Dextrose Noradrenaline/vasopressors Amiodarone IV Hypertonic saline Potassium >40 mmol/L Contrast media Aciclovir IV Phenytoin IV Diazepam IV

Extravasation Management Protocol

STOP infusion immediately — do NOT remove cannula yet
Aspirate as much drug as possible through cannula
Remove cannula after aspiration attempt
Photograph affected area (document size)
Elevate affected limb
Apply specific antidote if available (see below)
Document in medical record + incident report (Datix/equivalent)
Refer to plastic surgery if significant tissue damage suspected

Antidotes

Hypertonic/hyperosmolar solutions: Hyaluronidase (breaks down hyaluronic acid — disperses fluid)
Anthracyclines (doxorubicin etc): Dexrazoxane IV within 6 hours (Savene) — hospital pharmacy
Vinca alkaloids: Hyaluronidase + warm compress
Noradrenaline: Phentolamine (alpha-blocker) local infiltration

■ Types of Phlebitis

Mechanical Phlebitis
Caused by cannula movement/friction against vein wall. Large cannula in small vein, movement at insertion site, poor securing.
Prevention: Correct gauge selection, secure dressing, immobilisation.

Chemical Phlebitis
Caused by pH, osmolality, or drug irritation. Vesicant drugs, hypertonic solutions, rapid infusion of irritants.
Prevention: Dilute drugs appropriately, control infusion rate, use central access for vesicants.

Bacterial Phlebitis
Caused by contamination during insertion or manipulation. ANTT failure, prolonged dwell time, immunocompromised patient.
Prevention: ANTT, chlorhexidine prep, 72–96hr site rotation, hub decontamination.

GCC Regional Note: The following section addresses IV therapy considerations specific to healthcare practice across Gulf Cooperation Council countries — including Saudi Arabia, UAE, Qatar, Kuwait, Bahrain, and Oman.

△ High Ambient Temperature & IV Fluids

GCC countries experience extreme heat (summer temperatures 40–50°C ambient, vehicle interiors 60–80°C). This affects IV fluid integrity significantly.

Storage Guidelines

IV fluids must be stored in temperature-controlled pharmacy storage — typically 15–25°C
Never leave IV fluid bags in direct sunlight or in vehicles/ambulances during summer without cooling
Inspect all bags for discolouration, particulates, or bag deformation before administration — discard if abnormal
Heat degrades dextrose solutions faster — discolouration to yellow/amber is a sign of breakdown
PVC IV bags have higher leaching risk at elevated temperatures — follow manufacturer cold chain guidance

Ambulance / Pre-hospital IV Fluids

Emergency vehicles must have insulated drug storage. Check ambulance bag temperatures during summer. Rotate stock frequently. Do not administer fluids that have been left in a hot vehicle.

◆ Ramadan & IV Therapy

A significant proportion of GCC patients observe Ramadan fasting — sunrise to sunset. IV therapy during fasting requires cultural and religious sensitivity.

Islamic Scholarly Consensus (General)

IV saline / IV medications (non-nutritive): The majority of Islamic scholars consider these to NOT break the fast — they do not constitute food or drink entering via the natural pathway
IV glucose / dextrose: More contentious — some scholars consider nutritive IV to break the fast
Blood transfusions: Do not break the fast per most scholarly opinion

Best practice: Discuss with the patient and involve their religious advisor if the question arises. Document discussion in medical notes. Where clinically safe, schedule non-essential IV glucose after sunset (Iftar). Never withhold medically necessary IV therapy for religious reasons.

Nursing Approach

Acknowledge and respect the patient's religious practice
Explain medical necessity clearly if IV therapy is required during fasting hours
Schedule elective IV medications around fasting times where clinically appropriate
Document all discussions and patient agreement

⚠ KCl Restriction — JCI & GCC Compliance

The Joint Commission International (JCI) mandates that concentrated potassium chloride ampoules be removed from all ward areas and restricted to pharmacy and ICU/HDU with appropriate monitoring.

GCC Compliance Landscape

JCI-accredited hospitals (most major GCC private and public): Generally compliant — KCl removed from ward stock, pharmacy-prepared bags used
Non-accredited facilities: Variable compliance — concentrated KCl may still be available on wards in some smaller private clinics
Smart pump uptake: Growing rapidly in GCC — Saudi MOH standardisation programme promoting Alaris/BD Alaris/B Braun systems with drug library mandates

If you work in a facility where concentrated KCl is available on the ward: Raise this as a patient safety concern immediately. This is a NEVER EVENT risk. Escalate through your facility's safety reporting system.

■ Smart Pumps in GCC

Systems in Use

BD Alaris (formerly Cardinal Health): Widely used in Saudi Arabia, UAE, Qatar. Guardrails drug library.
B Braun Space / Perfusor: Common in Oman, Bahrain, Kuwait facilities.
ICU Medical (formerly Hospira): Plum 360 — used in some facilities.

Key Requirements

Drug library must be programmed and validated by pharmacy before use
Nurses must use drug library — not bypass ("free programming") for high-alert drugs
Soft and hard limit overrides must be documented
Regular drug library updates required — pharmacy responsibility
Saudi MOH National Programme for Patient Safety promotes standardised drug libraries across MOH hospitals

◆ Needlestick Injury — GCC Context

IV therapy contributes significantly to needlestick injury (NSI) risk. GCC healthcare workers face elevated risk due to high IV therapy workload, high patient-to-nurse ratios, and inconsistent use of safety-engineered devices.

Risk Reduction

Use safety-engineered IV catheters (auto-retractable needle) — mandated in many GCC facilities but compliance varies
Never recap needles — single-handed scoop technique only if recapping unavoidable
Sharps bin within arm's reach during all IV procedures
Report ALL needlestick injuries immediately — occupational health + infection control
Post-exposure prophylaxis (PEP) for HIV within 2 hours if high-risk source
Hepatitis B vaccination up to date — mandatory for healthcare workers in most GCC countries

GCC-specific: Some GCC hospitals do not consistently provide safety devices due to cost. Advocate for safety needles — it is your legal and professional right to work safely.

■ IV Therapy Nurse Specialist — GCC Career

INS Certification: CRNI

Certified Registered Nurse Infusion (CRNI) — awarded by the Infusion Nurses Society (INS, USA). Growing recognition in GCC as a valued advanced nursing credential.

Demonstrates advanced competency in: vascular access, infusion therapy, infection prevention, patient safety
Eligibility: RN licence + 1600 hours in infusion nursing within past 2 years
Exam: 150 questions, multiple-choice, CBT format
Renewal: every 3 years (CE credits + practice hours)

GCC IV Therapy Nurse Roles

IV Therapy Nurse Specialist: Manages difficult IV access, PICC/midline insertion, phlebitis prevention programmes
Vascular Access Team (VAT): Dedicated teams in major GCC hospitals (Riyadh, Dubai, Doha, Abu Dhabi) — proven to reduce CLABSI and peripheral IV failure rates
Saudi Commission for Health Specialties (SCHS) recognises CRNI for CME credit

Career tip: INS Standards of Practice (latest edition) is the global gold standard reference for infusion nursing — available from INS website. Many GCC hospitals have adopted INS standards as their institutional policy framework.

■ GCC IV Therapy Quick Reference

Topic	GCC Consideration	Action
KCl storage	JCI mandate — ward stock removal	Use pharmacy-prepared bags only; escalate if concentrated KCl on ward
Smart pumps	BD Alaris / B Braun most common	Use drug library; document all soft-limit overrides
IV fluid storage	Extreme heat — cold chain essential	Pharmacy storage 15–25°C; discard heat-exposed bags
Ramadan	Widespread fasting practice	Discuss with patient; schedule non-essential glucose IVs around fasting; document
Needlestick	High IV workload, inconsistent safety devices	Advocate for safety needles; report all NSI; PEP within 2hrs
CRNI certification	Growing GCC recognition	Consider for career development — INS website for eligibility
CLABSI	JCI-monitored metric in GCC hospitals	Maximal sterile barrier, scrub the hub, daily line review

IV Therapy & Intravenous Fluid Management